Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292
Clinical trial NCT01692184 · COMPLETED
Trial details
- NCT number
- NCT01692184
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2012-10-08
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.